FDMT 4D Molecular Therapeutics
- 5.440
- -0.400-6.85%
4D Molecular Therapeutics所有資訊
4D Molecular Therapeutics | 4：持股變動聲明-股東 RA CAPITAL MANAGEMENT, L.P.
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(10.7%)
4D Molecular Therapeutics | 3：首次持股聲明-股東 RA CAPITAL MANAGEMENT, L.P.
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(11.0%),Peter Kolchinsky(11.0%)等
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%)等
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Viking Global Investors LP(0.0%),Viking Global Opportunities Parent GP LLC(0.0%)等
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Janus Henderson Group plc(6.0%)
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Deep Track Capital, LP(7.88%),Deep Track Biotechnology Master Fund, Ltd.(7.88%)等
4D Molecular Therapeutics | 4：持股變動聲明- BVF PARTNERS L P/IL
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BVF Partners L.P.(14.2%),BVF Inc.(14.2%)等
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-The Vanguard Group(5.32%)
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(9.4%)
4D Molecular Therapeutics | SC 13G：超過5%持股股東披露文件-THE GOLDMAN SACHS GROUP, INC.(6.9 %),GOLDMAN SACHS & CO. LLC(6.9 %)
4D Molecular Therapeutics | SC 13G：超過5%持股股東披露文件-The Vanguard Group(5.32%)
4D Molecular Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-BlackRock, Inc.(9.4%)
4D Molecular Therapeutics | 4：持股變動聲明-高管 Bizily Scott
4D Molecular Therapeutics | 4：持股變動聲明-高管 Bizily Scott
4D Molecular Therapeutics | 3：首次持股聲明-股東 BVF PARTNERS L P/IL
4D Molecular Therapeutics | 4：持股變動聲明-高管 Bizily Scott
4D Molecular Therapeutics | 4：持股變動聲明-高管 Bizily Scott
暫無數據